review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.2174/138945010791011901 |
P698 | PubMed publication ID | 20199388 |
P2093 | author name string | Wim B van den Berg | |
Peter M van der Kraan | |||
Peter L van Lent | |||
Arjen B Blom | |||
P433 | issue | 5 | |
P921 | main subject | osteoarthritis | Q62736 |
P304 | page(s) | 620-629 | |
P577 | publication date | 2010-05-01 | |
P1433 | published in | Current Drug Targets | Q15724627 |
P1476 | title | To seek shelter from the WNT in osteoarthritis? WNT-signaling as a target for osteoarthritis therapy | |
P478 | volume | 11 |
Q47252258 | A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma |
Q92838130 | Accelerated development of instability-induced osteoarthritis in transgenic mice overexpressing SOST |
Q55331850 | Annexin A6 regulates catabolic events in articular chondrocytes via the modulation of NF-κB and Wnt/ß-catenin signaling. |
Q37956680 | Are we moving in the right direction with osteoarthritis drug discovery? |
Q38689933 | Association between serum and synovial fluid Dickkopf-1 levels with radiographic severity in primary knee osteoarthritis patients |
Q38094906 | Biologic agents in osteoarthritis: hopes and disappointments |
Q36903170 | CCN4 induces IL-6 production through αvβ5 receptor, PI3K, Akt, and NF-κB singling pathway in human synovial fibroblasts |
Q38335744 | Cardiovascular disease and osteoarthritis: common pathways and patient outcomes |
Q34375821 | Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. |
Q47570656 | Current status and future prospects for disease modification in osteoarthritis. |
Q35816932 | DNA methylation regulates sclerostin (SOST) expression in osteoarthritic chondrocytes by bone morphogenetic protein 2 (BMP-2) induced changes in Smads binding affinity to the CpG region of SOST promoter |
Q64897541 | Dishevelled‑2 modulates osteogenic differentiation of human synovial fibroblasts in osteoarthritis. |
Q40620359 | Effect of Laminin-A4 inhibition on cluster formation of human osteoarthritic chondrocytes. |
Q36051493 | Elevated expression of periostin in human osteoarthritic cartilage and its potential role in matrix degradation via matrix metalloproteinase-13. |
Q38472690 | Epigenetic differences in human cartilage between mild and severe OA. |
Q37974499 | Etiology of osteoarthritis: genetics and synovial joint development |
Q41677568 | Fluoxetine ameliorates cartilage degradation in osteoarthritis by inhibiting Wnt/β-catenin signaling |
Q50130520 | Inhibition of Wnt/β-catenin signaling ameliorates osteoarthritis in a murine model of experimental osteoarthritis. |
Q37690622 | Low-density lipoprotein receptor-related protein 5 governs Wnt-mediated osteoarthritic cartilage destruction |
Q37920768 | Mechanical loading: bone remodeling and cartilage maintenance |
Q92604807 | MiR93-5p inhibits chondrocyte apoptosis in osteoarthritis by targeting lncRNA CASC2 |
Q47114989 | Nitric Oxide Mediates Crosstalk between Interleukin 1β and WNT Signaling in Primary Human Chondrocytes by Reducing DKK1 and FRZB Expression |
Q35586231 | Pathogenetic mechanisms of posttraumatic osteoarthritis: opportunities for early intervention |
Q37364390 | Quantitative proteomics reveals regulatory differences in the chondrocyte secretome from human medial and lateral femoral condyles in osteoarthritic patients |
Q58560841 | The Role of Wnt Pathway in the Pathogenesis of OA and Its Potential Therapeutic Implications in the Field of Regenerative Medicine |
Q37816952 | The bone-cartilage unit in osteoarthritis |
Q36084937 | Tight regulation of wingless-type signaling in the articular cartilage - subchondral bone biomechanical unit: transcriptomics in Frzb-knockout mice |
Q41768626 | Will o' the wisp: CCN4 as a novel molecular target in osteoarthritis |
Search more.